BRD2 and cryptorchidism: Undoubtedly bilateral cryptorchidism may be considered an augmented risk factor although some authors found that either follicle-stimulating hormone (FSH) and testicular volume or long-term sperm count were comparable among patients who had undergone mono or bilateral cryptorchidism, if treated in due time [14].